View : 21 Download: 0

Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients: 12 Months Result of Phase 3 Clinical Trial

Title
Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients: 12 Months Result of Phase 3 Clinical Trial
Authors
Kwak, Jae-YongKim, HawkKim, Jeong A.Do, Young RokKim, Hyeoung JoonPark, Joon SeongChung, Joo SeopShin, Ho-JinKim, Sung-HyunKim, Dae-YoungBunworasate, UdomsakChoi, Chul WonComia, Narcisa Sonia CornejoZang, Dae YoungOh, SukjoongJootar, SaengsureeReksodiputro, Ary HarryantoLee, Won SikMun, Yeung-ChulKong, Jee HyunCaguioa, Priscilla B.Park, JinnyJung, Chul WonKim, Dong-Wook
Ewha Authors
문영철
SCOPUS Author ID
문영철scopus
Issue Date
2015
Journal Title
BLOOD
ISSN
0006-4971JCR Link1528-0020JCR Link
Citation
vol. 126, no. 23
Publisher
AMER SOC HEMATOLOGY
Indexed
SCI; SCIE; SCOPUS WOS
Appears in Collections:
의학전문대학원 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE